-
Mashup Score: 2
“Ultimately, we found that in this retrospective evaluation, there was no significant difference in recurrence-free survival in those who are treated with gemcitabine and docetaxel as compared to BCG,” says Ryan L. Steinberg, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1
“At a time when patients are increasingly concerned about prescription drugs, this information will provide a useful starting point for making essential medications as affordable as possible,” says Ruchika Talwar, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1Dr. Heidenberg describes HoLEP technique for BPH - 20 day(s) ago
“But I think that this really showed us that the outcomes were substantially better than I think any of us were thinking,” says Daniel J. Heidenberg, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2Study assesses projections for URiM representation in urology - 21 day(s) ago
“We found that in order to reach racial and ethnic parity in the urology residency graduates, there needs to be an increase of these graduates by 0.845% per year,” says Ashley Appleton.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1Qualified charitable distributions and avoiding taxes on RMDs - 1 month(s) ago
“At age 73, you must start taking distributions from the account in the form of required minimum distributions (RMDs), which are typically taxable. This means you must include the RMD in your income and pay income tax on the distributed amount,” writes Jeff Witz, CFP.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 7Why urologists should discuss adverse events with each other - 1 month(s) ago
“We must do more to help surgeons prepare for the impact of adverse events before they happen,” says Kevin Turner MA DM FRCS(Urol).
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2
Dr. Kirsh discusses his distinguished career and the evolution of urology practice in the United States.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Study of ProVee System for BPH hits enrollment goal - 1 month(s) ago
“The ProVee System has the potential to be a first-line interventional therapy for BPH that can be safely and reliably performed in the office setting,” says Steven A. Kaplan, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 5Dr. Sutherland on current options in tibial nerve stimulation - 1 month(s) ago
“Currently, in the area of tibial nerve stimulation, there are only 2 FDA approved options,” says Suzette E. Sutherland, MD, MS, FPMRS.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2
“I think it’s important that they go visit someone that does them. Go to the operating room, see it in person,” says Matthew E. Sterling, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
Dr. Ryan L. Steinberg discusses data showing that gemcitabine/docetaxel and BCG yield similar outcomes in patients with upper tract urothelial cell carcinoma. @ryansteinbergmd @uihealthcare #urology Watch now: https://t.co/ICfac8lBcJ